UnitedHealth Group Valuation
| UNH Stock | MXN 10,503 111.62 1.07% |
At this time, the company appears to be overvalued. UnitedHealth Group has a current Real Value of 8640.39 per share. The regular price of the company is 10503.09. Our model measures the value of UnitedHealth Group from inspecting the company fundamentals such as Shares Outstanding of 934.35 M, operating margin of 0.09 %, and Return On Equity of 0.25 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that UnitedHealth Group's price fluctuation is very steady at this time. Calculation of the real value of UnitedHealth Group is based on 3 months time horizon. Increasing UnitedHealth Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since UnitedHealth Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of UnitedHealth Stock. However, UnitedHealth Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10503.09 | Real 8640.39 | Hype 10503.09 | Naive 10631.1 |
The intrinsic value of UnitedHealth Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence UnitedHealth Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of UnitedHealth Group Incorporated helps investors to forecast how UnitedHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of UnitedHealth Group more accurately as focusing exclusively on UnitedHealth Group's fundamentals will not take into account other important factors: UnitedHealth Group Total Value Analysis
UnitedHealth Group Incorporated is at this time forecasted to have takeover price of 9.95 T with market capitalization of 8.64 T, debt of 54.51 B, and cash on hands of 22.56 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the UnitedHealth Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.95 T | 8.64 T | 54.51 B | 22.56 B |
UnitedHealth Group Investor Information
About 89.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.63. UnitedHealth Group recorded earning per share (EPS) of 397.95. The entity last dividend was issued on the 2nd of December 2022. Based on the analysis of UnitedHealth Group's profitability, liquidity, and operating efficiency, UnitedHealth Group Incorporated is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.UnitedHealth Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. UnitedHealth Group has an asset utilization ratio of 131.11 percent. This suggests that the Company is making 1.31 for each dollar of assets. An increasing asset utilization means that UnitedHealth Group Incorporated is more efficient with each dollar of assets it utilizes for everyday operations.UnitedHealth Group Ownership Allocation
UnitedHealth Group shows a total of 934.35 Million outstanding shares. The majority of UnitedHealth Group outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in UnitedHealth Group to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in UnitedHealth Group. Please pay attention to any change in the institutional holdings of UnitedHealth Group Incorporated as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.UnitedHealth Group Profitability Analysis
The company reported the revenue of 322.13 B. Net Income was 20.12 B with profit before overhead, payroll, taxes, and interest of 79.62 B.About UnitedHealth Group Valuation
Our relative valuation model uses a comparative analysis of UnitedHealth Group. We calculate exposure to UnitedHealth Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of UnitedHealth Group's related companies.UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. UNITEDHEALTH GROUP operates under Healthcare Plans classification in Mexico and is traded on Mexico Stock Exchange. It employs 330000 people.
8 Steps to conduct UnitedHealth Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates UnitedHealth Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct UnitedHealth Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain UnitedHealth Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine UnitedHealth Group's revenue streams: Identify UnitedHealth Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research UnitedHealth Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish UnitedHealth Group's growth potential: Evaluate UnitedHealth Group's management, business model, and growth potential.
- Determine UnitedHealth Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate UnitedHealth Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for UnitedHealth Stock Analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.